CNPY2-orchestrated unfolded protein responses play redundant roles in regulating anti-tumor immunity of CD8+T cells

被引：0
|
作者：
Wang, Yi [1 ]
Li, Anqi [1 ]
Song, No-Joon [1 ]
Shannon, Ariana E. [2 ]
Hong, Feng [1 ]
Searle, Brian C. [2 ]
Li, Zihai [1 ]
机构：
[1] Pelotonia Inst Immunooncol, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH USA
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.86.12
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tertiary lymphoid structures restrain cancer evolution by supporting stemlike CD8+T cells for sustained anti-tumor immunity
    Wang, Pengxiang
    Zhou, Chi
    Wei, Zhiting
    Wang, Yue
    Gao, Yuli
    Meng, Fangliangzi
    Zhou, Jian
    Fan, Jia
    Liu, Qi
    Sun, Yunfan
    CANCER RESEARCH, 2024, 84 (06)
  • [22] HDAC7 controls CD8+T cell dependent anti-viral and anti-tumor immunity
    Yerinde, Cansu
    Keye, Jacqueline
    Durlanik, Sibel
    Freise, Inka
    Schmidt, Franziska
    Schlickeiser, Stephan
    Obermayer, Benedikt
    Friedrich, Marie
    Wu, Hao
    Kunkel, Desiree
    Kuehl, Anja
    Bauer, Sebastian
    Thiel, Andreas
    Siegmund, Britta
    Glauben, Rainer
    Weidinger, Carl
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 45 - 45
  • [23] YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
    Ma, Shoubao
    Xiao, Sai
    Caligiuri, Michael
    Yu, Jianhua
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [24] Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells
    Biaolong Yang
    Biaolong Deng
    Xiao-Dong Jiao
    Bao-Dong Qin
    Yi Lu
    Weiqi Zhang
    Yixian Guo
    Shiqi Chen
    Dan Li
    Bin Li
    Yuan-Sheng Zang
    Cellular Oncology, 2022, 45 : 1297 - 1309
  • [25] Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells
    Yang, Biaolong
    Deng, Biaolong
    Jiao, Xiao-Dong
    Qin, Bao-Dong
    Lu, Yi
    Zhang, Weiqi
    Guo, Yixian
    Chen, Shiqi
    Li, Dan
    Li, Bin
    Zang, Yuan-Sheng
    CELLULAR ONCOLOGY, 2022, 45 (06) : 1297 - 1309
  • [26] The Potential of T Cell Factor 1 in Sustaining CD8+T Lymphocyte-Directed Anti-Tumor Immunity
    Jung, Sungmin
    Baek, Jea-Hyun
    CANCERS, 2021, 13 (03) : 1 - 17
  • [27] Generating Potent Anti-Tumor CD62Lhigh CD8+T Cells for Adoptive Immunotherapy
    Yang, Shicheng
    Zhang, Ling
    Zheng, Zhili
    Park, Tristen
    Rosenberg, Steven A.
    Morgan, Richard A.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 866 - 867
  • [28] NLRC5 potentiates anti-tumor CD8+T cells responses by activating interferon-β in endometrial cancer
    Zhang, Jing
    Guo, Bao
    Chen, Jia-Hua
    Liu, Xiao-Jing
    Zhang, Jun-Hui
    Zhu, Hai-Qing
    Wang, Wen-Yan
    Tang, Zhen-Hai
    Wei, Bing
    Cao, Yun-Xia
    Zhan, Lei
    TRANSLATIONAL ONCOLOGY, 2023, 36
  • [29] Radiotherapy enhances newly infiltrating CD8+T cells into tumor and exert an anti-tumor effects.
    Yamashita, Kimihiro
    Fukuoka, Eiji
    Watanabe, Akihiro
    Agawa, Kyosuke
    Yamada, Kota
    Takiguchi, Gosuke
    Urakawa, Naoki
    Hasegawa, Hiroshi
    Yamamoto, Masashi
    Kanaji, Shingo
    Matsuda, Yoshiko
    Matsuda, Takeru
    Oshikiri, Taro
    Nakamura, Tetsu
    Suzuki, Satoshi
    Kakeji, Yoshihiro
    CANCER SCIENCE, 2021, 112 : 738 - 738
  • [30] YAP is a novel regulator of CD4+and CD8+T cell during activation, differentiation, and anti-tumor immunity
    Szeto, Gregory Lee
    Stampouloglou, Elena
    Cheng, Nan
    Federico, Anthony
    Slaby, Emily
    Linton, Jonathan
    Livingston, Natalie
    Schneck, Jonathan P.
    Monti, Stefano
    Varelas, Xaralabos
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345